Jielin Xu

1.2k total citations
27 papers, 684 citations indexed

About

Jielin Xu is a scholar working on Molecular Biology, Neurology and Immunology. According to data from OpenAlex, Jielin Xu has authored 27 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Neurology and 5 papers in Immunology. Recurrent topics in Jielin Xu's work include Neuroinflammation and Neurodegeneration Mechanisms (10 papers), Bioinformatics and Genomic Networks (9 papers) and Single-cell and spatial transcriptomics (5 papers). Jielin Xu is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (10 papers), Bioinformatics and Genomic Networks (9 papers) and Single-cell and spatial transcriptomics (5 papers). Jielin Xu collaborates with scholars based in United States, China and Israel. Jielin Xu's co-authors include Feixiong Cheng, Andrew A. Pieper, James B. Leverenz, Yadi Zhou, Yuan Hou, Jeffrey L. Cummings, Lynn M. Bekris, Lang Li, Chien‐Wei Chiang and Marco Colonna and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Genome Research.

In The Last Decade

Jielin Xu

25 papers receiving 681 citations

Peers

Jielin Xu
Melody K. Morris United States
Tania Islam Bangladesh
Zhifa Han China
Yujie Cai China
Md. Shahjaman Bangladesh
Yunsheng He United States
Michel Friesenhahn United States
Melody K. Morris United States
Jielin Xu
Citations per year, relative to Jielin Xu Jielin Xu (= 1×) peers Melody K. Morris

Countries citing papers authored by Jielin Xu

Since Specialization
Citations

This map shows the geographic impact of Jielin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jielin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jielin Xu more than expected).

Fields of papers citing papers by Jielin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jielin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jielin Xu. The network helps show where Jielin Xu may publish in the future.

Co-authorship network of co-authors of Jielin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jielin Xu. A scholar is included among the top collaborators of Jielin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jielin Xu. Jielin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Jielin, Chengxi Zang, Chang Su, et al.. (2025). A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s disease. npj Parkinson s Disease. 11(1). 22–22. 4 indexed citations
4.
Xu, Jielin, et al.. (2024). Network medicine informed multiomics integration identifies drug targets and repurposable medicines for Amyotrophic Lateral Sclerosis. npj Systems Biology and Applications. 10(1). 128–128. 5 indexed citations
5.
6.
Xu, Junlin, Jielin Xu, Yajie Meng, et al.. (2023). Graph embedding and Gaussian mixture variational autoencoder network for end-to-end analysis of single-cell RNA sequencing data. Cell Reports Methods. 3(1). 100382–100382. 63 indexed citations
7.
Xu, Jielin, Lynn M. Bekris, Andrew A. Pieper, et al.. (2023). Multimodal omics analytic framework identifies microglial immunometabolism endophenotypes underlying sex differences in Alzheimer’s disease. Alzheimer s & Dementia. 19(S12). 1 indexed citations
8.
Gupta, Chirag, Jielin Xu, Ting Jin, et al.. (2022). Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer’s disease. PLoS Computational Biology. 18(7). e1010287–e1010287. 16 indexed citations
9.
Xu, Jielin, Chengsheng Mao, Yuan Hou, et al.. (2022). Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer’s disease. Cell Reports. 41(9). 111717–111717. 60 indexed citations
10.
Gupta, Chirag, Jielin Xu, Ting Jin, et al.. (2022). Single‐cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer’s disease. Alzheimer s & Dementia. 18(S4). 1 indexed citations
11.
Fang, Jiansong, Pengyue Zhang, Quan Wang, et al.. (2022). Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease. Alzheimer s Research & Therapy. 14(1). 7–7. 70 indexed citations
12.
Fu, Xin, et al.. (2022). Robustness Analysis and Modeling of UAV Cluster System Based on Complex Network. 743–748. 2 indexed citations
13.
Cheng, Feixiong, Yadi Zhou, Jielin Xu, et al.. (2022). Network medicine‐based multimodal omics analytic framework identifies immunometabolism endophenotypes underlying sex difference of Alzheimer’s disease. Alzheimer s & Dementia. 18(S3). 1 indexed citations
15.
Zhou, Yadi, Jielin Xu, Yuan Hou, et al.. (2021). Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. Alzheimer s Research & Therapy. 13(1). 110–110. 95 indexed citations
16.
Hou, Jinchao, Jue Zhang, Ping Cui, et al.. (2021). TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis. Journal of Clinical Investigation. 131(4). 159 indexed citations
17.
Yang, Guan, Wenqiang Song, Jielin Xu, et al.. (2020). Pik3c3 deficiency in myeloid cells imparts partial resistance to experimental autoimmune encephalomyelitis associated with reduced IL-1β production. Cellular and Molecular Immunology. 18(8). 2024–2039. 18 indexed citations
18.
Shukuya, Takehito, Tadaaki Yamada, Michael J. Koenig, et al.. (2019). The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(6). 1061–1076. 15 indexed citations
19.
Regan, Kelly, Jielin Xu, Megan Duggan, et al.. (2019). Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes. npj Systems Biology and Applications. 5(1). 6–6. 34 indexed citations
20.
Zhang, Tianyu, Jielin Xu, Siyuan Deng, et al.. (2018). Core signaling pathways in ovarian cancer stem cell revealed by integrative analysis of multi-marker genomics data. PLoS ONE. 13(5). e0196351–e0196351. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026